All Articles

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge

Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease

From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction

Obesity and diabetes in heart disease in women

Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)

From NAFLD to MASLD: transforming steatotic liver disease diagnosis and management

Role of skin enzymes in metabolism of topical drugs

Diabetes mellitus and heart disease

Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm

Dual etiology vs. MetALD: how MAFLD and MASLD address liver diseases coexistence

NAFLD to MAFLD: collaboration, not confusion - rethinking the naming of fatty liver disease

Epigenetic and epitranscriptomic regulations of metabolic dysfunction-associated steatotic liver disease

Prevention and control of risk factors in metabolic and alcohol-associated steatotic liver disease

Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects

Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways